SCHEDULE I - Agilon health, inc.

12 Months Ended

Dec. 31, 2024

Condensed Financial Information Disclosure [Abstract]

Condensed Financial Information Of Registrant

Schedule I: Condensed Financial Information Of Registrant

agilon health, inc.

(Parent Company Only)

CONDENSED BALANCE SHEETS

(in thousands, except per share data)

	December 31,
	2024		2023
ASSETS
Prepaid expenses and other current assets, net	$	404	$	344
Total current assets	404		344
Investment in wholly owned subsidiary	417,481		618,570
Loans receivable	53,155		61,862
Total assets	$	471,040	$	680,776
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)
Accounts payable and accrued expenses	$	—	$	16,639
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 412,194 and 406,387 shares issued and outstanding, respectively	4,122		4,064
Additional paid-in capital	2,053,895		1,986,899
Accumulated deficit	(1,586,977)		(1,326,826)
Total stockholders' equity (deficit)	471,040		664,137
Total liabilities and stockholders’ equity (deficit)	$	471,040	$	680,776

See accompanying Notes to the Condensed Financial Statements.

agilon health, inc.

(Parent Company Only)

CONDENSED STATEMENTS OF OPERATIONS

(in thousands)

	Year Ended December 31,
	2024		2023		2022
General and administrative	$	(1,152)	$	—	$	—
Equity in net income (loss) of subsidiary	(259,595)		(263,233)		(107,281)
Interest income	596		637		728
Net income (loss) attributable to common shares	$	(260,151)	$	(262,596)	$	(106,553)

See accompanying Notes to the Condensed Financial Statements.

agilon health, inc.

(Parent Company Only)

NOTES TO CONDENSED FINANCIAL STATEMENTS

NOTE 1. Description of agilon health, inc.

agilon health, inc., (“Parent”) was incorporated in Delaware and indirectly owns 100% of the equity interest in agilon health management, inc. (“agilon”). Parent has no significant operations or assets other than its indirect ownership of the equity of agilon. Accordingly, Parent is dependent upon distributions from agilon to fund its obligations. However, under the terms of the agreements governing agilon’s borrowings, agilon’s ability to pay dividends or lend to Parent is restricted. While certain exceptions to the paying of dividends or lending funds restrictions exist, these restrictions have resulted in the restricted net assets (as defined in Rule 4-08(e)(3) of Regulation S-X) of Parent’s subsidiaries exceeding 0.25% of the consolidated net assets of Parent and its subsidiaries. agilon has no obligation to pay dividends to Parent.

Condensed statements of cash flows have not been presented, as Parent did not have any cash as of, or for the years ended December 31, 2024, 2023 and 2022; see Note 3 for additional information on issuance of common stock.

NOTE 2. Basis of Presentation

The accompanying condensed Parent-only financial statements include the amounts of Parent and its investment in agilon under the equity method, and do not present the financial statements of Parent and agilon on a consolidated basis. Under the equity method, Parent’s investment in agilon is stated at cost plus contributions and equity in undistributed income (loss) of agilon less distributions received since the date of acquisition.

These condensed Parent-only financial statements have been prepared using the same accounting principles and policies described in the notes to the agilon health, inc. consolidated financial statements, with the only exception being that Parent accounts for its subsidiaries using the equity method. These condensed Parent-only financial statements should be read in conjunction with the agilon health, inc. consolidated financial statements and their accompanying notes.

NOTE 3. Equity

A discussion of Parent’s stockholders’ equity activities for the years ended December 31, 2024, 2023, and 2022 can be found in Note 13 in “Notes to the Consolidated Financial Statements” of the agilon health, inc. consolidated financial statements.

There were no cash dividends paid to Parent from agilon’s consolidated subsidiaries for the years ended December 31, 2024, 2023 and 2022.

Supplemental Cash Flow Information

The following table provides supplemental cash flow information (in thousands):

	Year Ended December 31,
	2024		2022
Supplemental disclosure of non-cash financing activities:
Settlement of liabilities through issuance of stock(1)	$	15,230	$	—
Non-cash investment in unconsolidated subsidiaries	—		190

_____________________________________________________________________

(1)For additional information regarding stock issuance, see Note 18 in “Notes to the Consolidated Financial Statements” of the agilon health, inc. consolidated financial statements.

NOTE 4. Stock Incentive Plan

A discussion of Parent’s Stock Incentive Plan for the years ended December 31, 2024, 2023 and 2022 can be found in Note 14 in the section, “Notes to the Consolidated Financial Statements” of the agilon health, inc. consolidated financial statements.